P3 Health Partners Files 8-K with Corporate Updates
Ticker: PIIIW · Form: 8-K · Filed: Mar 12, 2024 · CIK: 1832511
| Field | Detail |
|---|---|
| Company | P3 Health Partners Inc. (PIIIW) |
| Form Type | 8-K |
| Filed Date | Mar 12, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001, $11.50 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-action, filing, financials
TL;DR
P3 Health Partners filed an 8-K on March 12th, reporting corporate changes and financial docs.
AI Summary
P3 Health Partners Inc. filed an 8-K on March 12, 2024, reporting events as of March 8, 2024. The filing indicates amendments to articles of incorporation or bylaws and the filing of financial statements and exhibits. The company, formerly Foresight Acquisition Corp., changed its name on November 16, 2020.
Why It Matters
This 8-K filing signals corporate actions and the submission of financial information, which can impact investor understanding of the company's structure and financial health.
Risk Assessment
Risk Level: low — This filing is a routine corporate disclosure and does not appear to contain significant negative news or immediate financial distress.
Key Players & Entities
- P3 Health Partners Inc. (company) — Registrant
- Foresight Acquisition Corp. (company) — Former Company Name
- March 8, 2024 (date) — Date of earliest event reported
- March 12, 2024 (date) — Date of Report
- November 16, 2020 (date) — Date of Name Change
FAQ
What specific amendments were made to P3 Health Partners Inc.'s articles of incorporation or bylaws?
The filing indicates that amendments were made, but the specific details of these amendments are not provided in the summary information.
What financial statements and exhibits are being filed with this 8-K?
The filing states that Financial Statements and Exhibits are being filed, but the specific list or content of these documents is not detailed in the provided text.
What was the previous name of P3 Health Partners Inc. and when did the name change occur?
The previous name was Foresight Acquisition Corp., and the name change occurred on November 16, 2020.
What is the principal executive office address for P3 Health Partners Inc.?
The principal executive offices are located at 2370 Corporate Circle Suite 300 Henderson, Nevada 89074.
What is the business phone number for P3 Health Partners Inc.?
The business phone number is (702) 910-3950.
Filing Stats: 703 words · 3 min read · ~2 pages · Grade level 13.2 · Accepted 2024-03-12 16:13:58
Key Financial Figures
- $0.0001 — stered Class A common stock, par value $0.0001 per share PIII The Nasdaq Stock Market
- $11.50 — A common stock at an exercise price of $11.50 PIIIW The Nasdaq Stock Market LLC Ind
Filing Documents
- piii-20240308.htm (8-K) — 30KB
- piii-20240312xexx31.htm (EX-3.1) — 263KB
- piii-20240308_g1.jpg (GRAPHIC) — 201KB
- 0001628280-24-010546.txt ( ) — 969KB
- piii-20240308.xsd (EX-101.SCH) — 2KB
- piii-20240308_def.xml (EX-101.DEF) — 16KB
- piii-20240308_lab.xml (EX-101.LAB) — 28KB
- piii-20240308_pre.xml (EX-101.PRE) — 17KB
- piii-20240308_htm.xml (XML) — 4KB
03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. On March 8, 2024, the Board of Directors (the " Board ") of P3 Health Partners Inc., a Delaware corporation (the " Company "), approved and adopted amendments to the Company's bylaws (as amended, the " Amended and Restated Bylaws "), which became effective the same day. Among other things, the amendments contained in the Amended and Restated Bylaws: Address the universal proxy rules adopted by the U.S. Securities and Exchange Commission, by clarifying that no person may solicit proxies in support of a director nominee other than the Board's nominees unless such person has complied with Rule 14a-19 under the Securities Exchange Act of 1934, as amended (the " Exchange Act "), including applicable notice and solicitation requirements. Streamline procedural mechanics and enhance disclosure requirements in connection with stockholder nominations of directors and submissions of proposals regarding other business at stockholder meetings (other than proposals to be included in the Company's proxy materials pursuant to Rule 14a-8 under the Exchange Act), including, without limitation, by requiring additional background information and disclosures regarding proposing stockholders, proposed director nominees and business, and other persons related to a stockholder's solicitation of proxies. Require that a stockholder directly or indirectly soliciting proxies from other stockholders use a proxy card color other than white, which shall be reserved for exclusive use by the Board. The Amended and Restated Bylaws also delete certain obsolete provisions and incorporate certain technical, modernizing, clarifying and conforming changes. The foregoing description of the Amended and Restated Bylaws does not purport to be complete and is qualified in its entirety by reference to the full text of the Amended and Restated Bylaws, a copy of which is attached hereto as Exhibit 3.1 and is incorporated b
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 3.1 Amended and Restated Bylaws of P3 Health Partners Inc. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. P3 Health Partners Inc. Date: March 12, 2024 By: /s/ Atul Kavthekar Atul Kavthekar Chief Financial Officer